Aging
Navigate
Submit an Article
Research Paper|Volume 16, Issue 10|pp. 8998–9022
Breast cancer clinical outcomes and tumor immune microenvironment: cross-dialogue of multiple epigenetic modification profiles
Back to articleFigure 10(10 of 12)
100%
Figure 10
Figure 10.The comparison of IC50 value of anti-tumor drugs in high- and low-risk group.